SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

BrasilAgro Cuts 2026/27 Grain and Cotton Production Forecast by 3%

BrasilAgro lowered its forecast for grain and cotton production in the 2026/27 season by 3%.

SquawkNews Desk 3 updates Updated Nov 04, 2026, 01:12 AM UTC

Story updates

01:12:33 AM UTC
SquawkNews
BrasilAgro recorta 3% previsión de producción de granos y algodón para campaña 2026/27 a 439.300 ton
01:12:33 AM UTC
SquawkNews
BrasilAgro senkt Produktionsprognose für Getreide und Baumwolle 2026/27 um 3 Prozent auf 439'300 Ton
01:12:33 AM UTC
SquawkNews
BrasilAgro Cuts 2026/27 Grain and Cotton Production Forecast 3% to 439,300 Tons BrasilAgro on No

Related stories

AMD’s OpenAI and Meta Chip Deals Trigger a Quarterly Charge AMD’s agreements with OpenAI and Meta for chips result in a quarterly charge. M impact | EARNINGS | Nov 04, 2026, 02:11 AM UTC AMD books quarterly charge tied to OpenAI and Meta chip deals AMD reported total third-quarter non-cash charges of 66 cents per share. It expects to provide more guidance in 2027 on vesting and exercise conditions for the warrants. M impact | EARNINGS | Nov 04, 2026, 02:11 AM UTC AMD’s OpenAI and Meta chip deals trigger $1 billion quarterly charge AMD’s chip agreements with OpenAI and Meta are beginning to weigh on profits, with a $1 billion quarterly charge. M impact | EARNINGS | Nov 04, 2026, 02:10 AM UTC AMD Takes $1 Billion Quarterly Charge Tied to OpenAI, Meta Chip Deals AMD reported a $1 billion non-cash charge in the third quarter tied to its OpenAI and Meta chip deals. M impact | EARNINGS | Nov 04, 2026, 02:10 AM UTC City Chic Collective Expects Positive First-Half EBIT as Full-Price Sales Lift Margins City Chic Collective expects to return to positive first-half EBIT after reduced discounting lifted gross margins. Comparable full-price store sales rose 19.6% in Australia and New M impact | EARNINGS | Nov 04, 2026, 02:01 AM UTC Pfizer raises full-year outlook on strong anticoagulant, cancer drug sales Pfizer raised its full-year outlook. The supplied report says anticoagulant and cancer drug performance was strong. M impact | EARNINGS | Nov 04, 2026, 01:28 AM UTC